{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "13",
                "@year": "2020",
                "@timestamp": "2020-02-13T07:56:43.000043-05:00",
                "@month": "02"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2018",
                "@month": "01"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": {
                "xocs:funding-agency-matched-string": "Chulalongkorn University",
                "xocs:funding-agency-acronym": "CU",
                "xocs:funding-agency": "Chulalongkorn University",
                "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873",
                "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
            },
            "xocs:funding-addon-generated-timestamp": "2021-02-01T19:02:45.916569Z",
            "xocs:funding-text": "The authors would like to thank Associate Prof. Nutthada Areepium, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, for the valuable advice and suggestion in cancer treatment.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": [
                    {
                        "affiliation": {
                            "country": "Thailand",
                            "@afid": "60028190",
                            "@country": "tha",
                            "organization": [
                                {"$": "Department of Social and Administrative Pharmacy"},
                                {"$": "Faculty of Pharmaceutical Sciences"},
                                {"$": "Chulalongkorn University"}
                            ],
                            "affiliation-id": {
                                "@afid": "60028190",
                                "@dptid": "108180929"
                            },
                            "@dptid": "108180929"
                        },
                        "author": [
                            {
                                "ce:given-name": "Pornsroung",
                                "preferred-name": {
                                    "ce:given-name": "Pornsroung",
                                    "ce:initials": "P.",
                                    "ce:surname": "Saerekul",
                                    "ce:indexed-name": "Saerekul P."
                                },
                                "@seq": "1",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Saerekul",
                                "@auid": "57206694694",
                                "ce:indexed-name": "Saerekul P."
                            },
                            {
                                "ce:given-name": "Puree",
                                "preferred-name": {
                                    "ce:given-name": "Puree",
                                    "ce:initials": "P.",
                                    "ce:surname": "Anantachoti",
                                    "ce:indexed-name": "Anantachoti P."
                                },
                                "@seq": "3",
                                "ce:initials": "P.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Anantachoti",
                                "@auid": "6506845858",
                                "ce:indexed-name": "Anantachoti P."
                            },
                            {
                                "ce:given-name": "Rungpetch",
                                "preferred-name": {
                                    "ce:given-name": "Rungpetch",
                                    "ce:initials": "R.",
                                    "ce:surname": "Sakulbumrungsil",
                                    "ce:indexed-name": "Sakulbumrungsil R."
                                },
                                "@seq": "4",
                                "ce:initials": "R.",
                                "@_fa": "true",
                                "@type": "auth",
                                "ce:surname": "Sakulbumrungsil",
                                "@auid": "23089392500",
                                "ce:indexed-name": "Sakulbumrungsil R."
                            }
                        ]
                    },
                    {
                        "affiliation": {
                            "country": "United States",
                            "address-part": "784 Morris Turnpike",
                            "@afid": "60016360",
                            "@country": "usa",
                            "organization": [
                                {"$": "Department of Clinical Pharmacology"},
                                {"$": "Daiichi Sankyo"},
                                {"$": "Inc."}
                            ],
                            "affiliation-id": {
                                "@afid": "60016360",
                                "@dptid": "122188610"
                            },
                            "@dptid": "122188610"
                        },
                        "author": [{
                            "ce:given-name": "Tharin",
                            "preferred-name": {
                                "ce:given-name": "Tharin",
                                "ce:initials": "T.",
                                "ce:surname": "Limsakun",
                                "ce:indexed-name": "Limsakun T."
                            },
                            "@seq": "2",
                            "ce:initials": "T.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:surname": "Limsakun",
                            "@auid": "14043601000",
                            "ce:indexed-name": "Limsakun T."
                        }]
                    }
                ],
                "citation-title": "Access to medicines for breast, colorectal, and lung cancer in Thailand",
                "abstracts": "Â© 2018, Faculty of Pharmaceutical Sciences, Chulalongkorn University. All rights reserved.Aim: Cancer drugs have become prohibitive, and consequently their accessibility has increasingly been of great concern in many countries. Particularly, the information about cancer drug access in Thailand has been sporadic. Therefore, the goal of the study was to examine the antineoplastic drug accessibility in Thailand in terms of both market access and patient access. In addition, this study evaluated antineoplastic drugs based on cancer incidence in Thailand, and especially those for the top 3 common cancer types: Breast cancer, colorectal cancer, and lung cancer. Method: The study method was descriptive in nature to evaluate the number of antineoplastic drugs in both Thai market and reimbursement list or National List of Essential Medicines to reflect the market access and patient access, respectively. In determining Thailand\u2019s market access, the number of active ingredients (APIs) of antineoplastic drugs was obtained from the WHO website as a reference to the number of Thailand\u2019s marketing authorization approvals (MAAs) of antineoplastic drugs as per the Thai FDA website. For the determination of patient access, the number of antineoplastic drugs available to Thai patients was extracted from 2016 NLEM so that it can be compared to Thailand\u2019s MAAs. For further delineation with respect to treatments for each cancer type (ranked by cancer incidence in Thailand), the total number of APIs for each cancer type was used to determine market access and patient access. Results: The accessibility of antineoplastic drugs was 49% (88 of 180 APIs of WHO) for Thailand\u2019s market access and 43% (38 of 88 APIs in Thailand) for the patient access. For the top 3 cancer types, the market access was of a high percentage while the patient access from NLEM list was of low percentage. Conclusions: The market accessibility of antineoplastic drugs did not pose a problem for Thailand. Registrations of anti-cancer drugs undoubtedly played a key role for the market accessibility. However, new innovative antineoplastic drugs have presented a rather considerable concern for Thai patients, which are further complicated by the NLEM selection process and the limitation of use according to the categories outlined in the NLEM requirements. Therefore, improvement is clearly needed for patient access to new innovative antineoplastic drugs.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "postal-code": "10330",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Faculty of Pharmaceutical Sciences"},
                            {"$": "Chulalongkorn University"}
                        ]
                    },
                    "person": {
                        "ce:given-name": "Rungpetch",
                        "ce:initials": "R.",
                        "ce:surname": "Sakulbumrungsil",
                        "ce:indexed-name": "Sakulbumrungsil R."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Antineoplastic drug",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "Drug access",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "Market access",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "Patient access",
                            "@xml:lang": "eng"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "sourcetitle-abbrev": "Thai J. Pharm. Sci.",
                    "website": {"ce:e-address": {
                        "$": "http://www.tjps.pharm.chula.ac.th/ojs/index.php/tjps/article/download/623/195",
                        "@type": "email"
                    }},
                    "@country": "tha",
                    "translated-sourcetitle": {
                        "$": "Thai Journal of Pharmaceutical Sciences",
                        "@xml:lang": "eng"
                    },
                    "issn": [
                        {
                            "$": "19054637",
                            "@type": "electronic"
                        },
                        {
                            "$": "01254685",
                            "@type": "print"
                        }
                    ],
                    "volisspag": {
                        "voliss": {
                            "@volume": "42",
                            "@issue": "4"
                        },
                        "pagerange": {
                            "@first": "221",
                            "@last": "229"
                        }
                    },
                    "@type": "j",
                    "publicationyear": {"@first": "2018"},
                    "publisher": {
                        "affiliation": {
                            "address-part": "Phyathai Road",
                            "postal-code": "10330",
                            "@country": "tha",
                            "city": "Pathumwan, Bangkok"
                        },
                        "publishername": "Faculty of Pharmaceutical Sciences, Chulalongkorn University"
                    },
                    "sourcetitle": "Thai Journal of Pharmaceutical Sciences",
                    "@srcid": "19700175006",
                    "publicationdate": {
                        "year": "2018",
                        "date-text": {
                            "@xfab-added": "true",
                            "$": "2018"
                        }
                    }
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "16",
                                    "classification-description": "Cancer"
                                },
                                {
                                    "classification-code": "29",
                                    "classification-description": "Clinical and Experimental Biochemistry"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": [
                                {"$": "3004"},
                                {"$": "3003"}
                            ]
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "PHAR"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": {
                        "@source": "esbd",
                        "chemical": [
                            {
                                "cas-registry-number": [
                                    {"$": "216974-75-3"},
                                    {"$": "1438851-35-4"}
                                ],
                                "chemical-name": "bevacizumab"
                            },
                            {
                                "cas-registry-number": "154361-50-9",
                                "chemical-name": "capecitabine"
                            },
                            {
                                "cas-registry-number": "41575-94-4",
                                "chemical-name": "carboplatin"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "15663-27-1"},
                                    {"$": "26035-31-4"},
                                    {"$": "96081-74-2"}
                                ],
                                "chemical-name": "cisplatin"
                            },
                            {
                                "cas-registry-number": "50-18-0",
                                "chemical-name": "cyclophosphamide"
                            },
                            {
                                "cas-registry-number": "114977-28-5",
                                "chemical-name": "docetaxel"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "23214-92-8"},
                                    {"$": "25316-40-9"}
                                ],
                                "chemical-name": "doxorubicin"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "56390-09-1"},
                                    {"$": "56420-45-2"}
                                ],
                                "chemical-name": "epirubicin"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "253128-41-5"},
                                    {"$": "441045-17-6"}
                                ],
                                "chemical-name": "eribulin"
                            },
                            {
                                "cas-registry-number": "159351-69-6",
                                "chemical-name": "everolimus"
                            },
                            {
                                "cas-registry-number": "51-21-8",
                                "chemical-name": "fluorouracil"
                            },
                            {
                                "cas-registry-number": "103882-84-4",
                                "chemical-name": "gemcitabine"
                            },
                            {
                                "cas-registry-number": "219989-84-1",
                                "chemical-name": "ixabepilone"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "231277-92-2"},
                                    {"$": "388082-78-8"},
                                    {"$": "437755-78-7"}
                                ],
                                "chemical-name": "lapatinib"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "15475-56-6"},
                                    {"$": "59-05-2"},
                                    {"$": "7413-34-5"}
                                ],
                                "chemical-name": "methotrexate"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "1404-00-8"},
                                    {"$": "50-07-7"},
                                    {"$": "74349-48-7"}
                                ],
                                "chemical-name": "mitomycin"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "65271-80-9"},
                                    {"$": "70476-82-3"}
                                ],
                                "chemical-name": "mitoxantrone"
                            },
                            {
                                "cas-registry-number": "61825-94-3",
                                "chemical-name": "oxaliplatin"
                            },
                            {
                                "cas-registry-number": "33069-62-4",
                                "chemical-name": "paclitaxel"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "571190-30-2"},
                                    {"$": "827022-33-3"}
                                ],
                                "chemical-name": "palbociclib"
                            },
                            {
                                "cas-registry-number": "339177-26-3",
                                "chemical-name": "panitumumab"
                            },
                            {
                                "cas-registry-number": "947687-13-0",
                                "chemical-name": "ramucirumab"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "180288-69-1"},
                                    {"$": "1446410-98-5"}
                                ],
                                "chemical-name": "trastuzumab"
                            },
                            {
                                "cas-registry-number": "1018448-65-1",
                                "chemical-name": "trastuzumab emtansine"
                            },
                            {
                                "cas-registry-number": "865-21-4",
                                "chemical-name": "vinblastine"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "125317-39-7"},
                                    {"$": "71486-22-1"}
                                ],
                                "chemical-name": "vinorelbine tartrate"
                            }
                        ]
                    }}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "The authors would like to thank Associate Prof. Nutthada Areepium, Department of Pharmacy Practice, Faculty of Pharmaceutical Sciences, Chulalongkorn University, for the valuable advice and suggestion in cancer treatment.",
                        "@xml:lang": "eng"
                    },
                    "grant": {
                        "grant-acronym": "CU",
                        "grant-agency": {
                            "@iso-code": "tha",
                            "$": "Chulalongkorn University"
                        },
                        "grant-agency-id": "501100002873"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2019 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "26",
                    "@year": "2019",
                    "@timestamp": "BST 06:09:45",
                    "@month": "02"
                }},
                "itemidlist": {"itemid": [
                    {
                        "$": "2001535807",
                        "@idtype": "PUI"
                    },
                    {
                        "$": "915838473",
                        "@idtype": "CAR-ID"
                    },
                    {
                        "$": "20190125381",
                        "@idtype": "EMBASE"
                    },
                    {
                        "$": "20190321777",
                        "@idtype": "REAXYSCAR"
                    },
                    {
                        "$": "20190542803",
                        "@idtype": "SCOPUS"
                    },
                    {
                        "$": "20190001196173",
                        "@idtype": "TPA-ID"
                    },
                    {
                        "$": "85061855868",
                        "@idtype": "SCP"
                    },
                    {
                        "$": "85061855868",
                        "@idtype": "SGR"
                    }
                ]}
            },
            "tail": {"bibliography": {
                "@refcount": "23",
                "reference": [
                    {
                        "ref-fulltext": "Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84918815964",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "136"},
                                "pagerange": {
                                    "@first": "E359",
                                    "@last": "E386"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Ferlay",
                                        "ce:indexed-name": "Ferlay J."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Soerjomataram",
                                        "ce:indexed-name": "Soerjomataram I."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "R.",
                                        "@_fa": "true",
                                        "ce:surname": "Dikshit",
                                        "ce:indexed-name": "Dikshit R."
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Eser",
                                        "ce:indexed-name": "Eser S."
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "C.",
                                        "@_fa": "true",
                                        "ce:surname": "Mathers",
                                        "ce:indexed-name": "Mathers C."
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Rebelo",
                                        "ce:indexed-name": "Rebelo M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Int J Cancer"
                        }
                    },
                    {
                        "ref-fulltext": "Sriplung H, Khuhaprema T, Attasara P. Cancer incidence trends in Thailand, 1989-2000. Asian Pac J Cancer Prev 2006;7:239-44.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "Cancer incidence trends in Thailand, 1989-2000"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33748449311",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "7"},
                                "pagerange": {
                                    "@first": "239",
                                    "@last": "244"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Sriplung",
                                    "ce:indexed-name": "Sriplung H."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Khuhaprema",
                                    "ce:indexed-name": "Khuhaprema T."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Attasara",
                                    "ce:indexed-name": "Attasara P."
                                }
                            ]},
                            "ref-sourcetitle": "Asian Pac J Cancer Prev"
                        }
                    },
                    {
                        "ref-fulltext": "National Cancer Institute of Thailand. The Cancer Statistic. n.d. n.d. Available from: http://www.nci.go.th/th/cancer_record/cancer_rec1.html. [Last cited on 2016 Mar 16].",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.nci.go.th/th/cancer_record/cancer_rec1.html",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85061871511",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Last cited on",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "National Cancer Institute of Thailand",
                                "ce:indexed-name": "National Cancer Institute of Thailand"
                            }},
                            "ref-sourcetitle": "The Cancer Statistic"
                        }
                    },
                    {
                        "ref-fulltext": "Arruebo M, Vilaboa N, SÃ¡ez-Gutierrez B, Lambea J, Tres A, Valladares M, et al. Assessment of the evolution of cancer treatment therapies. Cancers 2011;3:3279-330.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Assessment of the evolution of cancer treatment therapies"},
                            "refd-itemidlist": {"itemid": {
                                "$": "80053217517",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "3"},
                                "pagerange": {
                                    "@first": "3279",
                                    "@last": "3330"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Arruebo",
                                        "ce:indexed-name": "Arruebo M."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "N.",
                                        "@_fa": "true",
                                        "ce:surname": "Vilaboa",
                                        "ce:indexed-name": "Vilaboa N."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "SÃ¡ez-Gutierrez",
                                        "ce:indexed-name": "Saez-Gutierrez B."
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "J.",
                                        "@_fa": "true",
                                        "ce:surname": "Lambea",
                                        "ce:indexed-name": "Lambea J."
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Tres",
                                        "ce:indexed-name": "Tres A."
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "M.",
                                        "@_fa": "true",
                                        "ce:surname": "Valladares",
                                        "ce:indexed-name": "Valladares M."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Cancers"
                        }
                    },
                    {
                        "ref-fulltext": "Abramson RG. Overview of Targeted Therapies for Cancer; 2016. Available from: https://www.mycancergenome.org/content/molecular-medicine/overview-of-targeted-therapies-for-cancer. [Last cited on 2016 Nov 13].",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.mycancergenome.org/content/molecular-medicine/overview-of-targeted-therapies-for-cancer",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "84978685765",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "Last cited on 2016 Nov 13",
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "R.G.",
                                "@_fa": "true",
                                "ce:surname": "Abramson",
                                "ce:indexed-name": "Abramson R.G."
                            }]},
                            "ref-sourcetitle": "Overview of Targeted Therapies for Cancer"
                        }
                    },
                    {
                        "ref-fulltext": "DeVita VT Jr, Chu E. A history of cancer chemotherapy. Cancer Res 2008;68:8643-53.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2008"},
                            "ref-title": {"ref-titletext": "A history of cancer chemotherapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "55349136976",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "68"},
                                "pagerange": {
                                    "@first": "8643",
                                    "@last": "8653"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "V.T.",
                                    "@_fa": "true",
                                    "ce:surname": "Devita",
                                    "ce:suffix": "Jr.",
                                    "ce:indexed-name": "Devita V.T."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "E.",
                                    "@_fa": "true",
                                    "ce:surname": "Chu",
                                    "ce:indexed-name": "Chu E."
                                }
                            ]},
                            "ref-sourcetitle": "Cancer Res"
                        }
                    },
                    {
                        "ref-fulltext": "Eckhardt S. History, present status and future prospects of anticancer drug therapy. CME J Gynecol Oncol 2000;5:312-7.",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2000"},
                            "ref-title": {"ref-titletext": "History, present status and future prospects of anticancer drug therapy"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0034522052",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "5"},
                                "pagerange": {
                                    "@first": "312",
                                    "@last": "317"
                                }
                            },
                            "ref-authors": {"author": [{
                                "@seq": "1",
                                "ce:initials": "S.",
                                "@_fa": "true",
                                "ce:surname": "Eckhardt",
                                "ce:indexed-name": "Eckhardt S."
                            }]},
                            "ref-sourcetitle": "CME J Gynecol Oncol"
                        }
                    },
                    {
                        "ref-fulltext": "Savage P, Mahmoud S. Development and economic trends in cancer therapeutic drugs: A 5-year update 2010-2014. Br J Cancer 2015;112:1037-41.",
                        "@id": "8",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-title": {"ref-titletext": "Development and economic trends in cancer therapeutic drugs: A 5-year update 2010-2014"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84925298403",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "112"},
                                "pagerange": {
                                    "@first": "1037",
                                    "@last": "1041"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Savage",
                                    "ce:indexed-name": "Savage P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.",
                                    "@_fa": "true",
                                    "ce:surname": "Mahmoud",
                                    "ce:indexed-name": "Mahmoud S."
                                }
                            ]},
                            "ref-sourcetitle": "Br J Cancer"
                        }
                    },
                    {
                        "ref-fulltext": "Bergmann L, Enzmann H, Thirstrup S, Schweim JK, Widera I, Zwierzina H, et al. Access to innovative oncology medicines in Europe. Ann Oncol 2016;27:353-6.",
                        "@id": "9",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Access to innovative oncology medicines in Europe"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84961664632",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "27"},
                                "pagerange": {
                                    "@first": "353",
                                    "@last": "356"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "L.",
                                        "@_fa": "true",
                                        "ce:surname": "Bergmann",
                                        "ce:indexed-name": "Bergmann L."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Enzmann",
                                        "ce:indexed-name": "Enzmann H."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Thirstrup",
                                        "ce:indexed-name": "Thirstrup S."
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "J.K.",
                                        "@_fa": "true",
                                        "ce:surname": "Schweim",
                                        "ce:indexed-name": "Schweim J.K."
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "I.",
                                        "@_fa": "true",
                                        "ce:surname": "Widera",
                                        "ce:indexed-name": "Widera I."
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "H.",
                                        "@_fa": "true",
                                        "ce:surname": "Zwierzina",
                                        "ce:indexed-name": "Zwierzina H."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Ann Oncol"
                        }
                    },
                    {
                        "ref-fulltext": "Chafe R, Culyer A, Dobrow M. Access to cancer drugs in Canada: Looking beyond coverage decisions. Healthcare Policy 2011;6:27-36.",
                        "@id": "10",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Access to cancer drugs in Canada: Looking beyond coverage decisions"},
                            "refd-itemidlist": {"itemid": {
                                "$": "79952904848",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "6"},
                                "pagerange": {
                                    "@first": "27",
                                    "@last": "36"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Chafe",
                                    "ce:indexed-name": "Chafe R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Culyer",
                                    "ce:indexed-name": "Culyer A."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.",
                                    "@_fa": "true",
                                    "ce:surname": "Dobrow",
                                    "ce:indexed-name": "Dobrow M."
                                }
                            ]},
                            "ref-sourcetitle": "Healthcare Policy"
                        }
                    },
                    {
                        "ref-fulltext": "Ades F, Zardavas D, Senterre C. Hurdles and delays in access to anti-cancer drugs in Europe. Ecancer Med Sci 2014;8:482.",
                        "@id": "11",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Hurdles and delays in access to anti-cancer drugs in Europe"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84919949607",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "8"},
                                "pagerange": {"@first": "482"}
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "F.",
                                    "@_fa": "true",
                                    "ce:surname": "Ades",
                                    "ce:indexed-name": "Ades F."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Zardavas",
                                    "ce:indexed-name": "Zardavas D."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.",
                                    "@_fa": "true",
                                    "ce:surname": "Senterre",
                                    "ce:indexed-name": "Senterre C."
                                }
                            ]},
                            "ref-sourcetitle": "Ecancer Med Sci"
                        }
                    },
                    {
                        "ref-fulltext": "Wilson A, Cohen J. Patient access to new cancer drugs in the United States and Australia. Value in Health 2011;14:944-52.",
                        "@id": "12",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2011"},
                            "ref-title": {"ref-titletext": "Patient access to new cancer drugs in the United States and Australia"},
                            "refd-itemidlist": {"itemid": {
                                "$": "80052760873",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "944",
                                    "@last": "952"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Wilson",
                                    "ce:indexed-name": "Wilson A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.",
                                    "@_fa": "true",
                                    "ce:surname": "Cohen",
                                    "ce:indexed-name": "Cohen J."
                                }
                            ]},
                            "ref-sourcetitle": "Value in Health"
                        }
                    },
                    {
                        "ref-fulltext": "Russo P, Mennini FS, Siviero PD, Rasi G. Time to market and patient access to new oncology products in Italy: A multistep pathway from European context to regional health care providers. Ann Oncol 2010;21:2081-7.",
                        "@id": "13",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Time to market and patient access to new oncology products in Italy: A multistep pathway from European context to regional health care providers"},
                            "refd-itemidlist": {"itemid": {
                                "$": "77957123635",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "21"},
                                "pagerange": {
                                    "@first": "2081",
                                    "@last": "2087"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Russo",
                                    "ce:indexed-name": "Russo P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "F.S.",
                                    "@_fa": "true",
                                    "ce:surname": "Mennini",
                                    "ce:indexed-name": "Mennini F.S."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "P.D.",
                                    "@_fa": "true",
                                    "ce:surname": "Siviero",
                                    "ce:indexed-name": "Siviero P.D."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Rasi",
                                    "ce:indexed-name": "Rasi G."
                                }
                            ]},
                            "ref-sourcetitle": "Ann Oncol"
                        }
                    },
                    {
                        "ref-fulltext": "Sruamsiri R, Ross-Degnan D, Lu CY. Expanding access to high-cost medicines through the E2 access program in Thailand: Effects on utilisation, health outcomes and cost using an interrupted time-series analysis. BMJ Open 2016;6:e010069.",
                        "@id": "14",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "Expanding access to high-cost medicines through the E2 access program in Thailand: Effects on utilisation, health outcomes and cost using an interrupted time-series analysis"},
                            "refd-itemidlist": {"itemid": [
                                {
                                    "$": "e010069",
                                    "@idtype": "ARTNUM"
                                },
                                {
                                    "$": "84962304260",
                                    "@idtype": "SGR"
                                }
                            ]},
                            "ref-volisspag": {"voliss": {"@volume": "6"}},
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Sruamsiri",
                                    "ce:indexed-name": "Sruamsiri R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "D.",
                                    "@_fa": "true",
                                    "ce:surname": "Ross-Degnan",
                                    "ce:indexed-name": "Ross-Degnan D."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Lu",
                                    "ce:indexed-name": "Lu C.Y."
                                }
                            ]},
                            "ref-sourcetitle": "BMJ Open"
                        }
                    },
                    {
                        "ref-fulltext": "United Nations Development Group. Indicators for Monitoring the Millennium Development Goals editor. United Nations, New York: United Nations Development Group; 2003.",
                        "@id": "15",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2003"},
                            "refd-itemidlist": {"itemid": {
                                "$": "30744450046",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "United Nations, New York: United Nations Development Group",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "United Nations Development Group",
                                "ce:indexed-name": "United Nations Development Group"
                            }},
                            "ref-sourcetitle": "Indicators for Monitoring the Millennium Development Goals Editor"
                        }
                    },
                    {
                        "ref-fulltext": "Iskrov G, Miteva-Katrandzhieva T, Stefanov R. Challenges to orphan drugs access in eastern Europe: The case of Bulgaria. Health Policy 2012;108:10-8.",
                        "@id": "16",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Challenges to orphan drugs access in eastern Europe: The case of Bulgaria"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84867335647",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "108"},
                                "pagerange": {
                                    "@first": "10",
                                    "@last": "18"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "G.",
                                    "@_fa": "true",
                                    "ce:surname": "Iskrov",
                                    "ce:indexed-name": "Iskrov G."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.",
                                    "@_fa": "true",
                                    "ce:surname": "Miteva-Katrandzhieva",
                                    "ce:indexed-name": "Miteva-Katrandzhieva T."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "Stefanov",
                                    "ce:indexed-name": "Stefanov R."
                                }
                            ]},
                            "ref-sourcetitle": "Health Policy"
                        }
                    },
                    {
                        "ref-fulltext": "Wileman H, Mishra A. Drug lag and key regulatory barriers in the emerging markets. Perspect Clin Res 2010;1:51-6.",
                        "@id": "17",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2010"},
                            "ref-title": {"ref-titletext": "Drug lag and key regulatory barriers in the emerging markets"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84862091002",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "1"},
                                "pagerange": {
                                    "@first": "51",
                                    "@last": "56"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Wileman",
                                    "ce:indexed-name": "Wileman H."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.",
                                    "@_fa": "true",
                                    "ce:surname": "Mishra",
                                    "ce:indexed-name": "Mishra A."
                                }
                            ]},
                            "ref-sourcetitle": "Perspect Clin Res"
                        }
                    },
                    {
                        "ref-fulltext": "Chung CJ, Huang WF. A study on drug innovation lag in Taiwan. J Food Drug Anal 2006;14:1-6.",
                        "@id": "18",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2006"},
                            "ref-title": {"ref-titletext": "A study on drug innovation lag in Taiwan"},
                            "refd-itemidlist": {"itemid": {
                                "$": "33646720683",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "14"},
                                "pagerange": {
                                    "@first": "1",
                                    "@last": "6"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Chung",
                                    "ce:indexed-name": "Chung C.J."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "W.F.",
                                    "@_fa": "true",
                                    "ce:surname": "Huang",
                                    "ce:indexed-name": "Huang W.F."
                                }
                            ]},
                            "ref-sourcetitle": "J Food Drug Anal"
                        }
                    },
                    {
                        "ref-fulltext": "Shafie AA, Chandriah H. Access to cancer drugs: Are we meeting the needs of Malaysian? J Cancer Policy 2017;13:30-2.",
                        "@id": "19",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2017"},
                            "ref-title": {"ref-titletext": "Access to cancer drugs: Are we meeting the needs of Malaysian?"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85030704882",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "13"},
                                "pagerange": {
                                    "@first": "30",
                                    "@last": "32"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Shafie",
                                    "ce:indexed-name": "Shafie A.A."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "H.",
                                    "@_fa": "true",
                                    "ce:surname": "Chandriah",
                                    "ce:indexed-name": "Chandriah H."
                                }
                            ]},
                            "ref-sourcetitle": "J Cancer Policy"
                        }
                    },
                    {
                        "ref-fulltext": "Chongtrakul P, Sumpradit N, Yoongthong W. ISafE and the evidence based approach for essential medicines selection in Thailand. Essential Drugs Monitor 2005;34:18-9.",
                        "@id": "20",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "ISafE and the evidence based approach for essential medicines selection in Thailand"},
                            "refd-itemidlist": {"itemid": {
                                "$": "72149105500",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "34"},
                                "pagerange": {
                                    "@first": "18",
                                    "@last": "19"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "P.",
                                    "@_fa": "true",
                                    "ce:surname": "Chongtrakul",
                                    "ce:indexed-name": "Chongtrakul P."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "N.",
                                    "@_fa": "true",
                                    "ce:surname": "Sumpradit",
                                    "ce:indexed-name": "Sumpradit N."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Yoongthong",
                                    "ce:indexed-name": "Yoongthong W."
                                }
                            ]},
                            "ref-sourcetitle": "Essential Drugs Monitor"
                        }
                    },
                    {
                        "ref-fulltext": "Thai-FDA, National List Essential Medicine B.E. 2559. Bureau of Drug Contol, MOPH Thailand; 2016.",
                        "@id": "21",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "refd-itemidlist": {"itemid": {
                                "$": "85061865714",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "MOPH Thailand",
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Thai-FDA",
                                "ce:indexed-name": "Thai-FDA"
                            }},
                            "ref-sourcetitle": "National List Essential Medicine B.E. 2559. Bureau of Drug Contol"
                        }
                    },
                    {
                        "ref-fulltext": "WHO. ATC/DDD Index 2015; 2015. Available from: https://www. whocc.no/atc_ddd_index/updates_included_in_the_atc_ddd_ index. [Last cited on 2016 Jan 22].",
                        "@id": "22",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2015"},
                            "ref-website": {"ce:e-address": {
                                "$": "https://www.whocc.no/atc_ddd_index/updates_included_in_the_atc_ddd_index",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85017488253",
                                "@idtype": "SGR"
                            }},
                            "ref-text": "[Last cited on 2016 Jan 22]",
                            "ref-sourcetitle": "WHO. ATC/DDD Index 2015"
                        }
                    },
                    {
                        "ref-fulltext": "Thai-FDA. Drug Search (Dserch) n.d. n.d. Available from: http://www.fdaolap.fda.moph.go.th/logistics/drgdrug/Dserch.asp. [Last cited on 2016 Aug 14].",
                        "@id": "23",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-website": {"ce:e-address": {
                                "$": "http://www.fdaolap.fda.moph.go.th/logistics/drgdrug/Dserch.asp",
                                "@type": "email"
                            }},
                            "refd-itemidlist": {"itemid": {
                                "$": "85061857924",
                                "@idtype": "SGR"
                            }},
                            "ref-authors": {"collaboration": {
                                "@seq": "1",
                                "ce:text": "Thai-FDA. Drug Search (Dserch)",
                                "ce:indexed-name": "Thai-FDA. Drug Search (Dserch)"
                            }}
                        }
                    }
                ]
            }}
        }
    },
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Basking Ridge",
            "@id": "60016360",
            "affilname": "Daiichi Sankyo, Inc.",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016360",
            "affiliation-country": "United States"
        }
    ],
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85061855868",
        "dc:description": "Aim: Cancer drugs have become prohibitive, and consequently their accessibility has increasingly been of great concern in many countries. Particularly, the information about cancer drug access in Thailand has been sporadic. Therefore, the goal of the study was to examine the antineoplastic drug accessibility in Thailand in terms of both market access and patient access. In addition, this study evaluated antineoplastic drugs based on cancer incidence in Thailand, and especially those for the top 3 common cancer types: Breast cancer, colorectal cancer, and lung cancer. Method: The study method was descriptive in nature to evaluate the number of antineoplastic drugs in both Thai market and reimbursement list or National List of Essential Medicines to reflect the market access and patient access, respectively. In determining Thailand\u2019s market access, the number of active ingredients (APIs) of antineoplastic drugs was obtained from the WHO website as a reference to the number of Thailand\u2019s marketing authorization approvals (MAAs) of antineoplastic drugs as per the Thai FDA website. For the determination of patient access, the number of antineoplastic drugs available to Thai patients was extracted from 2016 NLEM so that it can be compared to Thailand\u2019s MAAs. For further delineation with respect to treatments for each cancer type (ranked by cancer incidence in Thailand), the total number of APIs for each cancer type was used to determine market access and patient access. Results: The accessibility of antineoplastic drugs was 49% (88 of 180 APIs of WHO) for Thailand\u2019s market access and 43% (38 of 88 APIs in Thailand) for the patient access. For the top 3 cancer types, the market access was of a high percentage while the patient access from NLEM list was of low percentage. Conclusions: The market accessibility of antineoplastic drugs did not pose a problem for Thailand. Registrations of anti-cancer drugs undoubtedly played a key role for the market accessibility. However, new innovative antineoplastic drugs have presented a rather considerable concern for Thai patients, which are further complicated by the NLEM selection process and the limitation of use according to the categories outlined in the NLEM requirements. Therefore, improvement is clearly needed for patient access to new innovative antineoplastic drugs.",
        "prism:coverDate": "2018-01-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85061855868",
        "dc:creator": {"author": [{
            "ce:given-name": "Pornsroung",
            "preferred-name": {
                "ce:given-name": "Pornsroung",
                "ce:initials": "P.",
                "ce:surname": "Saerekul",
                "ce:indexed-name": "Saerekul P."
            },
            "@seq": "1",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Saerekul",
            "@auid": "57206694694",
            "author-url": "https://api.elsevier.com/content/author/author_id/57206694694",
            "ce:indexed-name": "Saerekul P."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85061855868"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85061855868&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85061855868&origin=inward"
            }
        ],
        "source-id": "19700175006",
        "citedby-count": "5",
        "prism:volume": "42",
        "subtype": "ar",
        "dc:title": "Access to medicines for breast, colorectal, and lung cancer in Thailand",
        "openaccess": null,
        "prism:issn": "19054637 01254685",
        "publishercopyright": "Â© 2018, Faculty of Pharmaceutical Sciences, Chulalongkorn University. All rights reserved.",
        "prism:issueIdentifier": "4",
        "subtypeDescription": "Article",
        "prism:publicationName": "Thai Journal of Pharmaceutical Sciences",
        "prism:pageRange": "221-229",
        "prism:endingPage": "229",
        "openaccessFlag": null,
        "prism:startingPage": "221",
        "dc:identifier": "SCOPUS_ID:85061855868",
        "dc:publisher": "Faculty of Pharmaceutical Sciences, Chulalongkorn UniversityPhyathai RoadPathumwan, Bangkok10330"
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Antineoplastic drug"
        },
        {
            "@_fa": "true",
            "$": "Drug access"
        },
        {
            "@_fa": "true",
            "$": "Market access"
        },
        {
            "@_fa": "true",
            "$": "Patient access"
        }
    ]},
    "subject-areas": {"subject-area": [
        {
            "@_fa": "true",
            "$": "Pharmacology",
            "@code": "3004",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        }
    ]},
    "authors": {"author": [
        {
            "ce:given-name": "Pornsroung",
            "preferred-name": {
                "ce:given-name": "Pornsroung",
                "ce:initials": "P.",
                "ce:surname": "Saerekul",
                "ce:indexed-name": "Saerekul P."
            },
            "@seq": "1",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Saerekul",
            "@auid": "57206694694",
            "author-url": "https://api.elsevier.com/content/author/author_id/57206694694",
            "ce:indexed-name": "Saerekul P."
        },
        {
            "ce:given-name": "Tharin",
            "preferred-name": {
                "ce:given-name": "Tharin",
                "ce:initials": "T.",
                "ce:surname": "Limsakun",
                "ce:indexed-name": "Limsakun T."
            },
            "@seq": "2",
            "ce:initials": "T.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60016360",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016360"
            },
            "ce:surname": "Limsakun",
            "@auid": "14043601000",
            "author-url": "https://api.elsevier.com/content/author/author_id/14043601000",
            "ce:indexed-name": "Limsakun T."
        },
        {
            "ce:given-name": "Puree",
            "preferred-name": {
                "ce:given-name": "Puree",
                "ce:initials": "P.",
                "ce:surname": "Anantachoti",
                "ce:indexed-name": "Anantachoti P."
            },
            "@seq": "3",
            "ce:initials": "P.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Anantachoti",
            "@auid": "6506845858",
            "author-url": "https://api.elsevier.com/content/author/author_id/6506845858",
            "ce:indexed-name": "Anantachoti P."
        },
        {
            "ce:given-name": "Rungpetch",
            "preferred-name": {
                "ce:given-name": "Rungpetch",
                "ce:initials": "R.",
                "ce:surname": "Sakulbumrungsil",
                "ce:indexed-name": "Sakulbumrungsil R."
            },
            "@seq": "4",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:surname": "Sakulbumrungsil",
            "@auid": "23089392500",
            "author-url": "https://api.elsevier.com/content/author/author_id/23089392500",
            "ce:indexed-name": "Sakulbumrungsil R."
        }
    ]}
}}